{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:17:12Z","timestamp":1788419832797,"version":"build-2803163510"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100017397","name":"UVA Cancer Center","doi-asserted-by":"publisher","award":["IDEA-Cancer pilot award"],"award-info":[{"award-number":["IDEA-Cancer pilot award"]}],"id":[{"id":"10.13039\/100017397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017397","name":"UVA Cancer Center","doi-asserted-by":"publisher","award":["Cancer Therapeutics (CRX) pilot award"],"award-info":[{"award-number":["Cancer Therapeutics (CRX) pilot award"]}],"id":[{"id":"10.13039\/100017397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sports Med - Open"],"DOI":"10.1186\/s40798-026-01101-1","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:30:46Z","timestamp":1788413446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Physical Exercise in Immunotherapy"],"prefix":"10.1186","volume":"12","author":[{"given":"Campbell M.","family":"Johnston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Tsung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7704-4365","authenticated-orcid":false,"given":"Hongji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"1101_CR1","unstructured":"Cancer Stat Facts: Common Cancer Sites. 2025; https:\/\/seer.cancer.gov\/statfacts\/html\/common.html#:~:text=In%202024%2C%20an%20estimated%20611%2C720,530."},{"issue":"5","key":"1101_CR2","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/0091-7435(92)90068-S","volume":"21","author":"Y Kusaka","year":"1992","unstructured":"Kusaka Y, Kondou H, Morimoto K. Healthy lifestyles are associated with higher natural killer cell activity. Prev Med. 1992;21(5):602\u201315.","journal-title":"Prev Med"},{"issue":"1","key":"1101_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S1047-2797(96)00071-3","volume":"7","author":"SH Olson","year":"1997","unstructured":"Olson SH, et al. Exercise, occupational activity, and risk of endometrial cancer. Ann Epidemiol. 1997;7(1):46\u201353.","journal-title":"Ann Epidemiol"},{"issue":"2","key":"1101_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jshs.2020.07.008","volume":"10","author":"Q Wang","year":"2021","unstructured":"Wang Q, Zhou W. Roles and molecular mechanisms of physical exercise in cancer prevention and treatment. J Sport Health Sci. 2021;10(2):201\u201310.","journal-title":"J Sport Health Sci"},{"key":"1101_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17155351","author":"A Avancini","year":"2020","unstructured":"Avancini A, et al. Exercise levels and preferences in cancer patients: a cross-sectional study. Int J Environ Res Public Health. 2020. https:\/\/doi.org\/10.3390\/ijerph17155351.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"1101_CR6","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1038\/s41467-020-17670-y","volume":"11","author":"C Robert","year":"2020","unstructured":"Robert C. A decade of immune-checkpoint inhibitors in cancer therapy. Nat Commun. 2020;11(1):3801.","journal-title":"Nat Commun"},{"issue":"8","key":"1101_CR7","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","volume":"186","author":"P Sharma","year":"2023","unstructured":"Sharma P, et al. Immune checkpoint therapy-current perspectives and future directions. Cell. 2023;186(8):1652\u201369.","journal-title":"Cell"},{"issue":"21","key":"1101_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70379","volume":"13","author":"SR Miller","year":"2024","unstructured":"Miller SR, et al. Pan-cancer survival impact of immune checkpoint inhibitors in a national healthcare system. Cancer Med. 2024;13(21):e70379.","journal-title":"Cancer Med"},{"issue":"10","key":"1101_CR9","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/j.immuni.2025.09.003","volume":"58","author":"CDM Alicea Pauneto","year":"2025","unstructured":"Alicea Pauneto CDM, et al. Intra-tumoral hypoxia promotes CD8(+) T cell dysfunction via chronic activation of integrated stress response transcription factor ATF4. Immunity. 2025;58(10):2489-2504 e8.","journal-title":"Immunity"},{"issue":"7","key":"1101_CR10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1158\/2326-6066.CIR-20-0499","volume":"9","author":"IL Gomes-Santos","year":"2021","unstructured":"Gomes-Santos IL, Amoozgar Z, Kumar AS, Ho WW, Roh K, Talele NP, et al. Exercise training improves tumor control by increasing CD8(+) T-cell infiltration via CXCR3 signaling and sensitizes breast cancer to immune checkpoint blockade. Cancer Immunol Res. 2021;9(7):765\u201378.","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"1101_CR11","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s40279-024-02031-2","volume":"54","author":"A He","year":"2024","unstructured":"He A, et al. The influence of exercise on cancer risk, the tumor microenvironment and the treatment of cancer. Sports Med. 2024;54(6):1371\u201397.","journal-title":"Sports Med"},{"key":"1101_CR12","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x2024e14144","volume":"57","author":"H Pan","year":"2024","unstructured":"Pan H, et al. Exercise: a non-drug strategy of NK cell activation. Braz J Med Biol Res. 2024;57:e14144.","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"1101_CR13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s12885-024-12224-7","volume":"24","author":"SN Miao","year":"2024","unstructured":"Miao SN, et al. Exercise accelerates recruitment of CD8(+) T cell to promotes anti-tumor immunity in lung cancer via epinephrine. BMC Cancer. 2024;24(1):474.","journal-title":"BMC Cancer"},{"issue":"9","key":"1101_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114697","volume":"43","author":"Z Luo","year":"2024","unstructured":"Luo Z, et al. Voluntary exercise sensitizes cancer immunotherapy via the collagen inhibition-orchestrated inflammatory tumor immune microenvironment. Cell Rep. 2024;43(9):114697.","journal-title":"Cell Rep"},{"issue":"1","key":"1101_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s40425-019-0699-5","volume":"7","author":"D Donnelly","year":"2019","unstructured":"Donnelly D, et al. The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients. J Immunother Cancer. 2019;7(1):222.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"1101_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.18632\/oncotarget.27464","volume":"11","author":"E Wennerberg","year":"2020","unstructured":"Wennerberg E, et al. Exercise reduces immune suppression and breast cancer progression in a preclinical model. Oncotarget. 2020;11(4):452\u201361.","journal-title":"Oncotarget"},{"issue":"7","key":"1101_CR17","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.ccell.2022.05.006","volume":"40","author":"E Kurz","year":"2022","unstructured":"Kurz E, et al. Exercise-induced engagement of the IL-15\/IL-15Ralpha axis promotes anti-tumor immunity in pancreatic cancer. Cancer Cell. 2022;40(7):720\u201337.","journal-title":"Cancer Cell"},{"issue":"8","key":"1101_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","volume":"24","author":"R Polak","year":"2024","unstructured":"Polak R, Zhang ET, Kuo CJ. Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment. Nat Rev Cancer. 2024;24(8):523\u201339.","journal-title":"Nat Rev Cancer"},{"key":"1101_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184668","author":"C Brummer","year":"2023","unstructured":"Brummer C, et al. Can exercise enhance the efficacy of checkpoint inhibition by modulating anti-tumor immunity? Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15184668.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"1101_CR20","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.it.2022.04.010","volume":"43","author":"J Zhang","year":"2022","unstructured":"Zhang J, et al. Turning cold tumors hot: from molecular mechanisms to clinical applications. Trends Immunol. 2022;43(7):523\u201345.","journal-title":"Trends Immunol"},{"issue":"9","key":"1101_CR21","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1016\/S1470-2045(20)30234-5","volume":"21","author":"M Ochoa de Olza","year":"2020","unstructured":"Ochoa de Olza M, et al. Turning up the heat on non-immunoreactive tumours: opportunities for clinical development. Lancet Oncol. 2020;21(9):e419\u201330.","journal-title":"Lancet Oncol"},{"key":"1101_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1335256","volume":"14","author":"B Hapuarachi","year":"2023","unstructured":"Hapuarachi B, et al. Exercise to transform tumours from cold to hot and improve immunotherapy responsiveness. Front Immunol. 2023;14:1335256.","journal-title":"Front Immunol"},{"issue":"12","key":"1101_CR23","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1249\/MSS.0000000000003250","volume":"55","author":"E Cho","year":"2023","unstructured":"Cho E, et al. Acute exercise increases NK cell mitochondrial respiration and cytotoxicity against triple-negative breast cancer cells under hypoxic conditions. Med Sci Sports Exerc. 2023;55(12):2132\u201342.","journal-title":"Med Sci Sports Exerc"},{"issue":"19","key":"1101_CR24","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1158\/0008-5472.CAN-21-1258","volume":"81","author":"L Yang","year":"2021","unstructured":"Yang L, et al. Effects of exercise on cancer treatment efficacy: a systematic review of preclinical and clinical studies. Cancer Res. 2021;81(19):4889\u201395.","journal-title":"Cancer Res"},{"issue":"1","key":"1101_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33432-4","volume":"13","author":"T Koivula","year":"2023","unstructured":"Koivula T, et al. The effect of acute exercise on circulating immune cells in newly diagnosed breast cancer patients. Sci Rep. 2023;13(1):6561.","journal-title":"Sci Rep"},{"issue":"2","key":"1101_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov H, et al. Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy. Br J Cancer. 2021;124(2):359\u201367.","journal-title":"Br J Cancer"},{"issue":"1","key":"1101_CR27","volume":"10","author":"ZW Luo","year":"2023","unstructured":"Luo ZW, et al. Physical exercise reverses immuno-cold tumor microenvironment via inhibiting SQLE in non-small cell lung cancer. Mil Med Res. 2023;10(1):39.","journal-title":"Mil Med Res"},{"key":"1101_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.888713","volume":"13","author":"J Gao","year":"2022","unstructured":"Gao J, Liang Y, Wang L. Shaping polarization of tumor-associated macrophages in cancer immunotherapy. Front Immunol. 2022;13:888713.","journal-title":"Front Immunol"},{"issue":"7","key":"1101_CR29","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","volume":"181","author":"F Klemm","year":"2020","unstructured":"Klemm F, et al. Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells. Cell. 2020;181(7):1643-1660 e17.","journal-title":"Cell"},{"issue":"1","key":"1101_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","volume":"8","author":"S Wang","year":"2024","unstructured":"Wang S, et al. Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. NPJ Precis Oncol. 2024;8(1):31.","journal-title":"NPJ Precis Oncol"},{"issue":"6","key":"1101_CR31","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ccell.2022.05.004","volume":"40","author":"K Kersten","year":"2022","unstructured":"Kersten K, et al. Spatiotemporal co-dependency between macrophages and exhausted CD8(+) T cells in cancer. Cancer Cell. 2022;40(6):624-638 e9.","journal-title":"Cancer Cell"},{"issue":"1","key":"1101_CR32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.immuni.2024.11.026","volume":"58","author":"J Waibl Polania","year":"2025","unstructured":"Waibl Polania J, et al. Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion. Immunity. 2025;58(1):232-246 e6.","journal-title":"Immunity"},{"key":"1101_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1292580","volume":"14","author":"DW Lyu","year":"2023","unstructured":"Lyu DW. Immunomodulatory effects of exercise in cancer prevention and adjuvant therapy: a narrative review. Front Physiol. 2023;14:1292580.","journal-title":"Front Physiol"},{"key":"1101_CR34","doi-asserted-by":"publisher","DOI":"10.1177\/1534735420949678","volume":"19","author":"MK Kim","year":"2020","unstructured":"Kim MK, et al. Effects of steady low-intensity exercise on high-fat diet stimulated breast cancer progression via the alteration of macrophage polarization. Integr Cancer Ther. 2020;19:1534735420949678.","journal-title":"Integr Cancer Ther"},{"issue":"1","key":"1101_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12906-025-04968-x","volume":"25","author":"H Kwon","year":"2025","unstructured":"Kwon H, et al. Anti-cancer effects of genistein supplementation and moderate-intensity exercise in high-fat diet-induced breast cancer via regulation of inflammation and adipose tissue metabolism in vivo and in vitro. BMC Complement Med Ther. 2025;25(1):223.","journal-title":"BMC Complement Med Ther"},{"issue":"12","key":"1101_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s13205-024-04150-z","volume":"14","author":"Z Lyu","year":"2024","unstructured":"Lyu Z, et al. Swimming upregulates APOL3 through regulating macrophage polarization to inhibit glycolysis and the development of melanoma. 3 Biotech. 2024;14(12):307.","journal-title":"3 Biotech"},{"issue":"9","key":"1101_CR37","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1158\/2326-6066.CIR-22-0465","volume":"11","author":"H Savage","year":"2023","unstructured":"Savage H, et al. Aerobic exercise alters the melanoma microenvironment and modulates ERK5 S496 phosphorylation. Cancer Immunol Res. 2023;11(9):1168\u201383.","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"1101_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0316692","volume":"20","author":"YW Eom","year":"2025","unstructured":"Eom YW, et al. TGF-beta expressed by M2 macrophages promotes wound healing by inhibiting TSG-6 expression by mesenchymal stem cells. PLoS ONE. 2025;20(4):e0316692.","journal-title":"PLoS ONE"},{"issue":"1","key":"1101_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1042\/CS20201236","volume":"135","author":"J van den Bulk","year":"2021","unstructured":"van den Bulk J, de Miranda N, Ten Dijke P. Therapeutic targeting of TGF-beta in cancer: hacking a master switch of immune suppression. Clin Sci (Lond). 2021;135(1):35\u201352.","journal-title":"Clin Sci (Lond)"},{"key":"1101_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104254","volume":"359","author":"R Weber","year":"2021","unstructured":"Weber R, et al. IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy. Cell Immunol. 2021;359:104254.","journal-title":"Cell Immunol"},{"issue":"1","key":"1101_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-020-0144-8","volume":"5","author":"X Wang","year":"2020","unstructured":"Wang X, et al. PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC. Signal Transduct Target Ther. 2020;5(1):38.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"1101_CR42","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1002\/eji.202048534","volume":"50","author":"J Koh","year":"2020","unstructured":"Koh J, et al. MDSC subtypes and CD39 expression on CD8(+) T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLC. Eur J Immunol. 2020;50(11):1810\u20139.","journal-title":"Eur J Immunol"},{"key":"1101_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.molimm.2019.11.008","volume":"118","author":"D Anestakis","year":"2020","unstructured":"Anestakis D, et al. Carboplatin chemoresistance is associated with CD11b(+)\/Ly6C(+) myeloid release and upregulation of TIGIT and LAG3\/CD160 exhausted T cells. Mol Immunol. 2020;118:99\u2013109.","journal-title":"Mol Immunol"},{"key":"1101_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004384","author":"R Bitsch","year":"2022","unstructured":"Bitsch R, et al. STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice. J Immunother Cancer. 2022. https:\/\/doi.org\/10.1136\/jitc-2021-004384.","journal-title":"J Immunother Cancer"},{"issue":"6","key":"1101_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234548","volume":"15","author":"J Garritson","year":"2020","unstructured":"Garritson J, et al. Physical activity delays accumulation of immunosuppressive myeloid-derived suppressor cells. PLoS ONE. 2020;15(6):e0234548.","journal-title":"PLoS ONE"},{"key":"1101_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1394420","volume":"15","author":"T Koivula","year":"2024","unstructured":"Koivula T, et al. The effect of exercise and disease status on mobilization of anti-tumorigenic and pro-tumorigenic immune cells in women with breast cancer. Front Immunol. 2024;15:1394420.","journal-title":"Front Immunol"},{"issue":"7","key":"1101_CR47","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/bjsports-2021-104243","volume":"56","author":"J Zylstra","year":"2022","unstructured":"Zylstra J, et al. Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial. Br J Sports Med. 2022;56(7):402\u20139.","journal-title":"Br J Sports Med"},{"key":"1101_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003917","author":"M Prasad","year":"2022","unstructured":"Prasad M, et al. MEK1\/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer. J Immunother Cancer. 2022. https:\/\/doi.org\/10.1136\/jitc-2021-003917.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"1101_CR49","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s10637-025-01570-3","volume":"43","author":"EM Kamel","year":"2025","unstructured":"Kamel EM, et al. Tackling tumor hypoxia: advances in breaking the oncogenic HIF-1alpha-p300\/CBP alliance. Invest New Drugs. 2025;43(4):1043\u201361.","journal-title":"Invest New Drugs"},{"issue":"1","key":"1101_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41577-025-01211-z","volume":"26","author":"AU Kabir","year":"2026","unstructured":"Kabir AU, et al. Linking tumour angiogenesis and tumour immunity. Nat Rev Immunol. 2026;26(1):35\u201351.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1101_CR51","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1038\/s41467-022-31764-9","volume":"13","author":"S Ma","year":"2022","unstructured":"Ma S, et al. Hypoxia induces HIF1alpha-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy. Nat Commun. 2022;13(1):4118.","journal-title":"Nat Commun"},{"key":"1101_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1265914","volume":"14","author":"H Yan","year":"2023","unstructured":"Yan H, et al. Exercise sensitizes PD-1\/PD-L1 immunotherapy as a hypoxia modulator in the tumor microenvironment of melanoma. Front Immunol. 2023;14:1265914.","journal-title":"Front Immunol"},{"issue":"1","key":"1101_CR53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11033-023-08931-2","volume":"51","author":"S Lin","year":"2023","unstructured":"Lin S, et al. The role of HIF in angiogenesis, lymphangiogenesis, and tumor microenvironment in urological cancers. Mol Biol Rep. 2023;51(1):14.","journal-title":"Mol Biol Rep"},{"key":"1101_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092292","author":"M Ghosh","year":"2022","unstructured":"Ghosh M, Lenkiewicz AM, Kaminska B. The interplay of tumor vessels and immune cells affects immunotherapy of glioblastoma. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10092292.","journal-title":"Biomedicines"},{"issue":"1","key":"1101_CR55","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jhep.2023.10.006","volume":"80","author":"L Zhang","year":"2024","unstructured":"Zhang L, et al. Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma. J Hepatol. 2024;80(1):82\u201398.","journal-title":"J Hepatol"},{"issue":"1","key":"1101_CR56","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13046-022-02366-6","volume":"41","author":"H Piao","year":"2022","unstructured":"Piao H, et al. A positive feedback loop between gastric cancer cells and tumor-associated macrophage induces malignancy progression. J Exp Clin Cancer Res. 2022;41(1):174.","journal-title":"J Exp Clin Cancer Res"},{"key":"1101_CR57","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1614336","volume":"2022","author":"G Zhang","year":"2022","unstructured":"Zhang G, et al. Hypoxia-driven M2-polarized macrophages facilitate cancer aggressiveness and temozolomide resistance in glioblastoma. Oxid Med Cell Longev. 2022;2022:1614336.","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"1101_CR58","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1152\/japplphysiol.00561.2022","volume":"134","author":"PB Elming","year":"1985","unstructured":"Elming PB, et al. The effect of single bout and prolonged aerobic exercise on tumor hypoxia in mice. J Appl Physiol (1985). 1985;134(3):692\u2013702.","journal-title":"J Appl Physiol (1985)"},{"issue":"1","key":"1101_CR59","doi-asserted-by":"publisher","first-page":"13966","DOI":"10.1038\/s41598-019-49582-3","volume":"9","author":"CA Florez Bedoya","year":"2019","unstructured":"Florez Bedoya CA, et al. Exercise during preoperative therapy increases tumor vascularity in pancreatic tumor patients. Sci Rep. 2019;9(1):13966.","journal-title":"Sci Rep"},{"issue":"6","key":"1101_CR60","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.cell.2020.02.029","volume":"180","author":"A Crinier","year":"2020","unstructured":"Crinier A, et al. Snapshot: natural killer cells. Cell. 2020;180(6):1280-1280 e1.","journal-title":"Cell"},{"issue":"2","key":"1101_CR61","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000510315","volume":"13","author":"Y Lee","year":"2021","unstructured":"Lee Y, Shin H, Kim J. In vivo anti-cancer effects of resveratrol mediated by NK cell activation. J Innate Immun. 2021;13(2):94\u2013106.","journal-title":"J Innate Immun"},{"issue":"3","key":"1101_CR62","doi-asserted-by":"publisher","first-page":"910","DOI":"10.7150\/ijbs.100948","volume":"21","author":"X Yu","year":"2025","unstructured":"Yu X, et al. Immunosenescence, physical exercise, and their implications in tumor immunity and immunotherapy. Int J Biol Sci. 2025;21(3):910\u201339.","journal-title":"Int J Biol Sci"},{"issue":"10","key":"1101_CR63","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.1172\/JCI137585","volume":"130","author":"Y Yang","year":"2020","unstructured":"Yang Y, et al. Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells. J Clin Invest. 2020;130(10):5508\u201322.","journal-title":"J Clin Invest"},{"issue":"1","key":"1101_CR64","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/bju.15842","volume":"131","author":"SS Djurhuus","year":"2023","unstructured":"Djurhuus SS, et al. Exercise training to increase tumour natural killer-cell infiltration in men with localised prostate cancer: a randomised controlled trial. BJU Int. 2023;131(1):116\u201324.","journal-title":"BJU Int"},{"issue":"3","key":"1101_CR65","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.cmet.2016.01.011","volume":"23","author":"L Pedersen","year":"2016","unstructured":"Pedersen L, et al. Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution. Cell Metab. 2016;23(3):554\u201362.","journal-title":"Cell Metab"},{"issue":"2","key":"1101_CR66","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","volume":"26","author":"IG House","year":"2020","unstructured":"House IG, et al. Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade. Clin Cancer Res. 2020;26(2):487\u2013504.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1101_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2026.102589","volume":"7","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, et al. Preoperative exercise induces anti-tumor Kupffer cells to prevent surgical stress-promoted colorectal cancer liver metastasis. Cell Rep Med. 2026;7(2):102589.","journal-title":"Cell Rep Med"},{"key":"1101_CR68","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008722","author":"BL Schlechter","year":"2024","unstructured":"Schlechter BL, Stebbing J. CCR5 and CCL5 in metastatic colorectal cancer. J Immunother Cancer. 2024. https:\/\/doi.org\/10.1136\/jitc-2023-008722.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"1101_CR69","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.2010905","volume":"11","author":"ES Melese","year":"2022","unstructured":"Melese ES, et al. CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development. Oncoimmunology. 2022;11(1):2010905.","journal-title":"Oncoimmunology"},{"key":"1101_CR70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4103\/ijpvm.IJPVM_93_20","volume":"13","author":"M Esmailiyan","year":"2022","unstructured":"Esmailiyan M, et al. Effects of 8-week noncontinuous aerobic exercise on the levels of CCL2, CCL5, and their respective receptors in female BALB\/C mice suffering from breast cancer. Int J Prev Med. 2022;13:55.","journal-title":"Int J Prev Med"},{"issue":"1","key":"1101_CR71","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000599","volume":"8","author":"C Bergamaschi","year":"2020","unstructured":"Bergamaschi C, et al. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-gamma, CXCL9 and CXCL10. J Immunother Cancer. 2020;8(1):e000599.","journal-title":"J Immunother Cancer"},{"key":"1101_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107318","volume":"91","author":"S Zhang","year":"2021","unstructured":"Zhang S, et al. Biological effects of IL-15 on immune cells and its potential for the treatment of cancer. Int Immunopharmacol. 2021;91:107318.","journal-title":"Int Immunopharmacol"},{"key":"1101_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1053137","volume":"13","author":"Z Luo","year":"2022","unstructured":"Luo Z, et al. Exercise-induced IL-15 acted as a positive prognostic implication and tumor-suppressed role in pan-cancer. Front Pharmacol. 2022;13:1053137.","journal-title":"Front Pharmacol"},{"key":"1101_CR74","doi-asserted-by":"publisher","first-page":"p. 1184703","DOI":"10.3389\/fphar.2023.1184703","volume":"14","author":"M Cai","year":"2023","unstructured":"Cai M, et al. Research progress of interleukin-15 in cancer immunotherapy. Front Pharmacol. 2023;14:1184703.","journal-title":"Front Pharmacol"},{"key":"1101_CR75","doi-asserted-by":"publisher","first-page":"p. 487","DOI":"10.3389\/fimmu.2020.00487","volume":"11","author":"JM Jubel","year":"2020","unstructured":"Jubel JM, et al. The role of PD-1 in acute and chronic infection. Front Immunol. 2020;11:487.","journal-title":"Front Immunol"},{"issue":"8","key":"1101_CR76","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/s41590-021-00975-5","volume":"22","author":"MS Abdel-Hakeem","year":"2021","unstructured":"Abdel-Hakeem MS, et al. Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation. Nat Immunol. 2021;22(8):1008\u201319.","journal-title":"Nat Immunol"},{"key":"1101_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.964442","volume":"13","author":"Q Tang","year":"2022","unstructured":"Tang Q, et al. The role of PD-1\/PD-L1 and application of immune-checkpoint inhibitors in human cancers. Front Immunol. 2022;13:964442.","journal-title":"Front Immunol"},{"issue":"1","key":"1101_CR78","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12885-019-5364-3","volume":"19","author":"M Chen","year":"2019","unstructured":"Chen M, et al. Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PD-L1) production and transport in colon cancer stem cells. BMC Cancer. 2019;19(1):153.","journal-title":"BMC Cancer"},{"key":"1101_CR79","first-page":"0360","volume":"7","author":"J Liu","year":"2024","unstructured":"Liu J, et al. Crosstalk between exercise and immunotherapy: current understanding and future directions. Research (Wash D C). 2024;7:0360.","journal-title":"Research (Wash D C)"},{"issue":"1","key":"1101_CR80","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40164-022-00275-0","volume":"11","author":"XF Liu","year":"2022","unstructured":"Liu XF, et al. Physical activity improves outcomes of combined lenvatinib plus anti-PD-1 therapy in unresectable hepatocellular carcinoma: a retrospective study and mouse model. Exp Hematol Oncol. 2022;11(1):20.","journal-title":"Exp Hematol Oncol"},{"key":"1101_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/v13061128","author":"A Kwan","year":"2021","unstructured":"Kwan A, Winder N, Muthana M. Oncolytic virotherapy treatment of breast cancer: barriers and recent advances. Viruses. 2021. https:\/\/doi.org\/10.3390\/v13061128.","journal-title":"Viruses"},{"issue":"3","key":"1101_CR82","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3892\/mmr.2026.13803","volume":"33","author":"CH Hsieh","year":"2026","unstructured":"Hsieh CH, Chuang PC. Converting \u201ccold\u201d to \u201chot\u201d hepatocellular carcinoma for improved immunotherapy (Review). Mol Med Rep. 2026;33(3):93.","journal-title":"Mol Med Rep"},{"key":"1101_CR83","first-page":"100","volume":"26","author":"A Martin-Ruiz","year":"2020","unstructured":"Martin-Ruiz A, et al. Benefits of exercise and immunotherapy in a murine model of human non-small-cell lung carcinoma. Exerc Immunol Rev. 2020;26:100\u201315.","journal-title":"Exerc Immunol Rev"},{"issue":"1","key":"1101_CR84","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12885-022-09349-y","volume":"22","author":"G Holmen Olofsson","year":"2022","unstructured":"Holmen Olofsson G, et al. High intensity aerobic exercise training and immune cell mobilization in patients with lung cancer (HI AIM)-a randomized controlled trial. BMC Cancer. 2022;22(1):246.","journal-title":"BMC Cancer"},{"key":"1101_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15010334","author":"M Gouez","year":"2026","unstructured":"Gouez M, et al. Feasibility and preliminary efficacy of aerobic acute exercise prior to immunotherapy and chemotherapy infusion in patients with metastatic non-small cell lung cancer: a randomized controlled trial. J Clin Med. 2026. https:\/\/doi.org\/10.3390\/jcm15010334.","journal-title":"J Clin Med"},{"key":"1101_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2025.107101","volume":"277","author":"K Leuchte","year":"2026","unstructured":"Leuchte K, et al. The cancer-immunity cycle in motion: the effects of exercise on antitumor immunity. Immunol Lett. 2026;277:107101.","journal-title":"Immunol Lett"},{"issue":"10","key":"1101_CR87","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1038\/s41591-024-03143-y","volume":"30","author":"AE Hiensch","year":"2024","unstructured":"Hiensch AE, et al. Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial. Nat Med. 2024;30(10):2957\u201366.","journal-title":"Nat Med"},{"issue":"12","key":"1101_CR88","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.6004\/jnccn.2020.7603","volume":"18","author":"AA Kirkham","year":"2020","unstructured":"Kirkham AA, et al. Impact of exercise on chemotherapy tolerance and survival in early-stage breast cancer: a nonrandomized controlled trial. J Natl Compr Canc Netw. 2020;18(12):1670\u20137.","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"1101_CR89","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10549-021-06163-1","volume":"187","author":"P Sheean","year":"2021","unstructured":"Sheean P, et al. Every day counts: a randomized pilot lifestyle intervention for women with metastatic breast cancer. Breast Cancer Res Treat. 2021;187(3):729\u201341.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1101_CR90","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13102-025-01094-6","volume":"17","author":"A Hamad","year":"2025","unstructured":"Hamad A, et al. Understanding the mechanism behind preoperative exercise therapy in patients with gastrointestinal cancers: a prospective randomized clinical trial. BMC Sports Sci Med Rehabil. 2025;17(1):50.","journal-title":"BMC Sports Sci Med Rehabil"},{"issue":"3","key":"1101_CR91","first-page":"216","volume":"20","author":"AR Morielli","year":"2021","unstructured":"Morielli AR, et al. Feasibility, safety, and preliminary efficacy of exercise during and after neoadjuvant rectal cancer treatment: a phase II randomized controlled trial. Clin Colorectal Cancer. 2021;20(3):216\u201326.","journal-title":"Clin Colorectal Cancer"},{"issue":"12","key":"1101_CR92","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.6004\/jnccn.2023.7065","volume":"21","author":"C Neuzillet","year":"2023","unstructured":"Neuzillet C, et al. Effect of adapted physical activity in patients with advanced pancreatic cancer: the APACaP GERCOR randomized trial. J Natl Compr Canc Netw. 2023;21(12):1234-1242 e17.","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Sports Medicine - Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40798-026-01101-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40798-026-01101-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40798-026-01101-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:02:03Z","timestamp":1788418923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40798-026-01101-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1101"],"URL":"https:\/\/doi.org\/10.1186\/s40798-026-01101-1","relation":{},"ISSN":["2198-9761"],"issn-type":[{"value":"2198-9761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable to this manuscript.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable to this manuscript.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing financial or non-financial interests.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"130"}}